Omnicell

JANUARY 10, 2023

Bethany Donato Director, Product Marketing On November 1, the U.S. Pharmacopeia (USP) published revisions to the general chapters on compounding Nonsterile <795> and Sterile <797> preparations, including robotic technology for the very first time.

Sterile Compounds 98

Sterile Compounds Compounding Omnicell Patient Care 98

Omnicell

JANUARY 10, 2023

Bethany Donato Director, Product Marketing Achieving the five rights of medication administration is often a destination without a map, failing to acknowledge human factors and system weaknesses that contribute to errors. And one of the highest areas of opportunity for human error is in the sterile compounding process.

Sterile Compounds 93

Sterile Compounds Compounding Omnicell Communication 93

Omnicell

JANUARY 10, 2023

Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. The number of improperly prepared IVs is staggering. Insourcing IV compounding services at Moses H. 5 at 2 p.m.

Sterile Compounds 52

Sterile Compounds Omnicell Compounding Hospitals 52

Omnicell

JANUARY 10, 2023

Arpit Mehta Director of Pharmacy, Allegheny General Hospital Like many health systems, we at Allegheny Health Network have been challenged by the cost, compliance, and complexity of compounding sterile products (CSPs). We were highly dependent on purchasing ready-to-use IV medications from 503B vendors.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.

Sterile Compounds 52

Sterile Compounds Omnicell Compounding Hospitals 52

Omnicell

SEPTEMBER 5, 2022

Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Labelling 52

Omnicell

JANUARY 10, 2023

DiCubellis, RPh, MPH Senior Director of Pharmacy Services for the University of Maryland Medical System and Senior Director of Pharmacy, University of Maryland Medical Center Healthcare systems are under increasing pressure to ensure IV solutions are prepared safely and accurately while adhering to increasingly stringent regulations.

Compounding 52

Compounding Omnicell Sterile Compounds Hospitals 52